Hearing Highlights Problems with India’s Industrial Policy

India's Harmful Industrial Policies Gaining Center Stage

06.27.13 | By Jay Taylor

Today, Rep. Terry (R. NE) chairman of the House Energy and Commerce Subcommittee on Commerce, Manufacturing and Trade held a hearing to highlight how India’s industrial policy is hurting U.S. companies and workers.  India’s harmful industrial policies have gained center stage over the last month, witnessed by the fact that nearly 250 House and Senate members have sent letters to the Administration expressing frustration about how those policies hurt U.S. businesses and workers. 
PhRMA has witnessed a sustained deterioration of the innovation climate in India.  We seek a trading relationship where India plays by the same rules as the United States.  This will not only be good for our member companies, but also businesses from other sectors, U.S. jobs, and patients around the world.  Our industry recognizes the challenges the Indian Government faces in extending healthcare to its vast population.  Still, we cannot ignore the need to foster investment into existing and future innovations that many patients rely on for treatment today and which will be critical to meeting the unmet medical needs of patients in the future.  At the same time, there must be a focus on ensuring access to essential medicines, many of which are readily available as generics.  After all, India is a leader in the production of low-cost, generic medicines.  If our collective end goal is to address India’s public health challenges and to continue to provide life-saving medicines for all patients who need them, we must work together to identify sustainable solutions to healthcare financing, infrastructure, environmental and societal factors.
PhRMA joined a group of associations that share similar concerns regarding India’s policies to form the Alliance for Fair Trade with India or AFTI.  At the hearing, the AFTI co-chairs, Linda Dempsey of the National Association of Manufacturers (NAM) and Mark Elliot of the Global Intellectual Property Center of the U.S. Chamber of Commerce, both highlighted the damaging effects India’s policies are having on the U.S. economy.
India can be a great partner.  We continue to hope that we can find ways to work with India that will foster the recognition of the value of innovation and how it can lead to better lives for the people of both of our countries.  The more the United States, India, and other nations can cooperate in ensuring an environment that understands and respects intellectual property rights, the more we all will prosper.


Hide Comments

More On PhRMA — powered by PhRMApedia


Cost in Context